[go: up one dir, main page]

ATE303816T1 - Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten - Google Patents

Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten

Info

Publication number
ATE303816T1
ATE303816T1 AT00936234T AT00936234T ATE303816T1 AT E303816 T1 ATE303816 T1 AT E303816T1 AT 00936234 T AT00936234 T AT 00936234T AT 00936234 T AT00936234 T AT 00936234T AT E303816 T1 ATE303816 T1 AT E303816T1
Authority
AT
Austria
Prior art keywords
preventing
viral infection
therapeutic use
transplant rejection
new therapeutic
Prior art date
Application number
AT00936234T
Other languages
English (en)
Inventor
Girish J Kotwal
Futwan Al-Mohanna
Ranjit Parhar
Original Assignee
King Faisal Specialist Hospita
Univ Louisville Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Faisal Specialist Hospita, Univ Louisville Res Found filed Critical King Faisal Specialist Hospita
Application granted granted Critical
Publication of ATE303816T1 publication Critical patent/ATE303816T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00936234T 1999-05-25 2000-05-24 Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten ATE303816T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13613499P 1999-05-25 1999-05-25
PCT/US2000/014203 WO2000071147A1 (en) 1999-05-25 2000-05-24 Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection

Publications (1)

Publication Number Publication Date
ATE303816T1 true ATE303816T1 (de) 2005-09-15

Family

ID=22471455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936234T ATE303816T1 (de) 1999-05-25 2000-05-24 Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten

Country Status (7)

Country Link
EP (1) EP1185283B1 (de)
AT (1) ATE303816T1 (de)
AU (1) AU5158000A (de)
CA (1) CA2374681C (de)
DE (1) DE60022499T2 (de)
HK (1) HK1045456B (de)
WO (1) WO2000071147A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070116672A1 (en) * 2003-09-05 2007-05-24 Kotwal Girish J Treatment of rheumatic diseases
US8043609B2 (en) 2004-10-08 2011-10-25 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders
WO2006042252A2 (en) * 2004-10-08 2006-04-20 Potentia Pharmeceuticals, Inc. Viral complement control proteins for eye disorders
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
ES2879430T3 (es) 2012-11-15 2021-11-22 Apellis Pharmaceuticals Inc Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
US10308687B2 (en) 2013-03-15 2019-06-04 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
WO2017062879A2 (en) 2015-10-07 2017-04-13 Apellis Pharmaceuticals, Inc. Dosing regimens
BR112019020955A2 (pt) 2017-04-07 2020-05-05 Apellis Pharmaceuticals Inc regimes de dosagem e composições e métodos relacionados

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157110A (en) * 1988-08-20 1992-10-20 The Government Of The United States Of America Synthetic, anti-complement protein
EP1413587A2 (de) * 1991-05-03 2004-04-28 Washington University Modifizierter Regulator des Komplementsystems
US6013256A (en) * 1996-09-24 2000-01-11 Protein Design Labs, Inc. Method of preventing acute rejection following solid organ transplantation

Also Published As

Publication number Publication date
AU5158000A (en) 2000-12-12
CA2374681A1 (en) 2000-11-30
HK1045456A1 (en) 2002-11-29
EP1185283B1 (de) 2005-09-07
HK1045456B (zh) 2006-09-08
DE60022499T2 (de) 2006-11-30
DE60022499D1 (de) 2005-10-13
EP1185283A4 (de) 2003-07-02
EP1185283A1 (de) 2002-03-13
WO2000071147A1 (en) 2000-11-30
CA2374681C (en) 2011-07-05

Similar Documents

Publication Publication Date Title
EA200601467A1 (ru) Макроциклические соединения в качестве ингибиторов вирусной репликации
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
EP1441720B8 (de) Hemmer von serin-protease, insbesondere von hepatitis-c-virus-ns3-ns4a-protease, mit einem kondensierten ringsystem
EA201170969A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
TR199903053T2 (xx) Benzimidazol t�revleri.
ECSP034493A (es) Inhibidores de proteasa peptidomimeticos
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
DE69531944D1 (de) Neue hiv-protease-inhibitoren
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ATE303816T1 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
ATE215952T1 (de) Hiv-proteaseinhibitoren
DE60143078D1 (de) Pax2 zur behandlung von nierenkrankheiten
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
DK1331940T3 (da) Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
ATE468130T1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
RU94045140A (ru) Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний
BR0016654A (pt) Composto, método para o tratamento da dor, e, composição farmacêutica
DE60134881D1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
UY26735A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties